U.S. flag

An official website of the United States government

Display Settings:

Format

Send to:

Choose Destination
Mecasermin (Increlex): CADTH Reimbursement Recommendation: Indication: For the treatment of growth failure in children and adolescents from 2 to 18 years with confirmed severe primary insulin-like growth factor-1 deficiency [Internet].

Mecasermin (Increlex): CADTH Reimbursement Recommendation: Indication: For the treatment of growth failure in children and adolescents from 2 to 18 years with confirmed severe primary insulin-like growth factor-1 deficiency [Internet].

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Feb.

Table of contents


Supplemental Content

Search details

See more...

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...